← Leaderboards
Paul Dempsey
Cynvenio Biosystems, Inc.
$1,375,079
Attributed
$1,375,079
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $997.9K · FY2011–13$1M$750K$500K$250K$0
'11
'12
'13
Funding mix
By agency
NIH$1,375,079 · 3
By mechanism
N44$997,908 · 1
N43$377,171 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesMalignant NeoplasmsBiopsyMutationSamplingDetectionBaseMutation DetectionTechnologySolidTumorBlood CirculationMolecularNeoplastic CellGenotypeMalignant Neoplasm Of LungMolecular PathologyMedicineDiagnosticBlood SpecimenCohortGene MutationCharacteristicsBiological Markers
Grant awards (3)
Developing predictive biomarkers in metastatic breast cancer using LiquidBiopsy$997,908
N44 · FY2013 · CA · contact PI
TAS::75 0849::TAS SBIR TOPIC 277 - NOVEL CTC-BASED TEST FOR LUNG CANCER DRUG RES$195,030
N43 · FY2011 · CA · contact PI
TAS::75 0849::TAS "TOPIC 293, A LIQUID BIOPSY TO ASSESS MUTATION IN LUNG CANCER"$182,141
N43 · FY2011 · CA · contact PI